164 related articles for article (PubMed ID: 1761737)
1. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
[TBL] [Abstract][Full Text] [Related]
3. A review of the pharmacokinetics of cefpodoxime proxetil.
Borin MT
Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
[TBL] [Abstract][Full Text] [Related]
4. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Frampton JE; Brogden RN; Langtry HD; Buckley MM
Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
Borin MT; Hughes GS; Spillers CR; Patel RK
Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
Kees F; Wellenhofer M; Bröhl K; Grobecker H
Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
[TBL] [Abstract][Full Text] [Related]
8. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
Fulton B; Perry CM
Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
[TBL] [Abstract][Full Text] [Related]
10. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.
Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.
Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT
Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
Borin MT; Ferry JJ; Forbes KK; Hughes GS
J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
[TBL] [Abstract][Full Text] [Related]
14. Multiple dose pharmacokinetics of cefpodoxime in young adult and elderly patients.
Backhouse C; Wade A; Williamson P; Tremblay D; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():29-34. PubMed ID: 2292527
[TBL] [Abstract][Full Text] [Related]
15. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Stevens DL; Pien F; Drehobl M
Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
[TBL] [Abstract][Full Text] [Related]
17. Disposition of cefpodoxime proxetil in hemodialysis patients.
Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
J Clin Pharmacol; 1992 Nov; 32(11):1038-44. PubMed ID: 1474165
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.
Couraud L; Andrews JM; Lecoeur H; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():35-40. PubMed ID: 2292528
[TBL] [Abstract][Full Text] [Related]
19. The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.
Borin MT; Forbes KK; Hughes GS
Biopharm Drug Dispos; 1995 May; 16(4):295-302. PubMed ID: 7548778
[TBL] [Abstract][Full Text] [Related]
20. Cefpodoxime pharmacokinetics in children: effect of food.
Kearns GL; Abdel-Rahman SM; Jacobs RF; Wells TG; Borin MT
Pediatr Infect Dis J; 1998 Sep; 17(9):799-804. PubMed ID: 9779765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
